Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
Blood Advances|May 8, 2020
Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study resultsClaude Gardin, Cécile Pautas, Elise Fournier, et al.
JAMA Dermatology|September 8, 2021
UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS SyndromeEve Zakine, Bérénice Schell, Maxime Battistella, et al.
British Journal of Haematology|July 14, 2018
Myelodysplastic syndrome (MDS) with isolated trisomy 8: a type of MDS frequently associated with myeloproliferative features? A report by the Groupe Francophone des MyélodysplasiesLouis Drevon, Alice Marceau, Odile Maarek, et al.
Blood Cancer Journal|June 24, 2022
A multiparametric niche-like drug screening platform in acute myeloid leukemiaReinaldo Dal Bello, Justine Pasanisi, Romane Joudinaud, et al.
Blood|March 10, 2021
Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMMLMargaux Sevin, Franck Debeurme, Lucie Laplane, et al.
Hemasphere|June 17, 2026
CEBP and ZEB2 alterations define three distinct subtypes of B-cell acute lymphoblastic leukemiaRathana Kim, Marie Passet, Hugo Bergugnat, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 13, 2021
Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy: A Prospective Observational Study From the Acute Leukaemia French Association (ALFA) GroupMauricette Michallet, Mohamad Sobh, Stephane Morisset, et al.
Blood|August 19, 2021
Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapyRaphael Itzykson, Elise Fournier, Céline Berthon, et al.
Haematologica|May 15, 2025
Clinical benefit of tafasitamab plus lenalidomide in relapsed or refractory diffuse large Bcell lymphoma: real-world data from the EarlyMIND studyGabriel Brisou, Jérôme Paillassa, Sophie Bernard, et al.
The Journal of Clinical Investigation|November 15, 2024
CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemiaPaul Deschamps, Margaux Wacheux, Axel Gosseye, et al.
Pageof 15